FDA Expands Approved Use of Imbruvica For Rare Form of non-Hodgkin Lymphoma
(FDA.gov) Jan 29, 2015 - First drug approved to treat Waldenström’s macroglobulinemia.
read press release »
Putting Precision Medicine For Cancer at Work in America's Largest Hospital
(Forbes) Jan 29, 2015 - In one of the largest initiatives of its kind, the for-profit hospital chain Hospital Corporation of America (HCA) has embarked on a plan to molecularly profile the tumor of cancer patients, marry the genomic information to clinical data from a patient’s electronic health record, and recommend targeted therapies.
read article »
Scoring Progress Against Cancer: New Tool Measures Cancer Progress to Help Inform Research and Policy Decisions
(Lilly) Jan 29, 2015 - On the eve of World Cancer Day 2015, amidst the ongoing cost-of-cancer-care debate, PACE (Patient Access to Cancer care Excellence), a Lilly Oncology initiative, is launching the PACE Continuous Innovation Indicators™ (CII). CII is the first evidence-based, customizable online tool to review progress against cancer over time—initially covering 12 cancer types.
read corporate press release »
View ALL News »